Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand.

ABSTRACT:

Background

Public health care payer organizations face increasing pressures to make transparent and sustainable coverage decisions about ever more expensive prescription drugs, suggesting a need for public engagement in coverage decisions. However, little is known about countries' approaches to integrating public preferences in existing funding decisions. The aim of this study was to describe how Belgium and New Zealand used deliberative processes to engage the public and to identify lessons learned from these countries' approaches.

Methods

To describe two countries' deliberative processes, we first reviewed key country policy documents and then conducted semi-structured interviews with five leaders of the processes from Belgium and New Zealand. We assessed each country's ra

SUBMITTER: Leopold C 

PROVIDER: S-EPMC7183657 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature